18 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
for a Three-Year Term Expiring at the 2026 Annual Meeting
INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
Independence Of The Board … Of The Board Of Directors
Audit Committee
Compensation Committee
Nominating and Corporate Governance Committee
Stockholder Communications With The Board
8-K
EX-99.1
d3nytf8
14 Nov 22
Acumen Pharmaceuticals Reports Third Quarter 2022
4:10pm
DEF 14A
i8mx4
27 Apr 22
Definitive proxy
5:03pm
10-K
8svsbpcyle li
28 Mar 22
Annual report
4:51pm
10-K
EX-10.3
5agomik4
28 Mar 22
Annual report
4:51pm
10-Q
kwuox
16 Aug 21
Quarterly report
4:51pm
424B4
t4619p80tem
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.2
hemjt paq8ywst
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
2ghm5sevqt6dcm
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.3
cvmo1tx czx
24 Jun 21
IPO registration (amended)
8:17am
S-1
pwkbsnr ofu5x
9 Jun 21
IPO registration
5:02pm
DRS/A
yqronptsxwta
14 May 21
Draft registration statement (amended)
12:00am
DRS
bdglgi
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next